Adaptimmune Therapeutics plc (ADAP)
Healthcare, Biotechnology
Market cap: 185.49MRecommendation: buy
PE: N/A
Previous close: 0.68
$0.7249 USD
+6.60% change today
-3.19% change last month
5D 1M 6M 1Y
Inversely correlated stocks:
CTRE DXCM RWT More >>More data :
Price-to-book : 4.17Average analyst target: 2.26667